Filing Overview
Registrant: Tivic Health Systems, Inc. The request metadata identifies Valion Bio, Inc., but the filing itself names Tivic Health Systems, Inc.
Form and date: Form 8-K dated November 14, 2022, reporting the company’s financial results for the third fiscal quarter ended September 30, 2022.
Reported items: Items 2.02 and 7.01. The company furnished a press release as Exhibit 99.1 regarding its third-quarter financial results and Regulation FD disclosure. The provided filing text does not include the press release’s financial details.
Financial Results and Key Metrics
- Revenue: The filing text does not provide a clear value.
- Profit or loss: The filing text does not provide a clear value.
- Cash flow and margins: No amounts or margin data are provided in the filing text.
- Debt and liquidity: No debt, cash balance, liquidity, or financing information is provided in the filing text.
- Other metrics: No operating or financial metrics are included beyond the reference to the separate Exhibit 99.1 press release.
Changes Versus Prior Comparable Period
The filing announces third-quarter financial results but does not include the underlying results or comparative figures. Accordingly, material changes versus the prior comparable period cannot be determined from the provided text.
Outlook, Risks, and Unusual Items
- The filing does not provide specific financial guidance or a quantified outlook.
- It contains customary forward-looking-statement language and cautions that actual results may differ materially because of known and unknown risks and uncertainties.
- No specific contingency, restructuring, impairment, financing transaction, or other unusual item is described in the provided filing text.
- The results disclosure, including Exhibit 99.1, was furnished rather than filed for purposes of Section 18 of the Exchange Act and is not incorporated by reference except where expressly stated.
Investor Verification Checklist
- Obtain and review Exhibit 99.1 for revenue, net loss, cash flow, margins, balance-sheet data, and year-over-year comparisons.
- Verify the company identity because the request metadata names Valion Bio, Inc., while the filing identifies Tivic Health Systems, Inc. and ticker TIVC.
- Review the company’s quarterly filing for cash runway, debt obligations, liquidity risks, and any subsequent financing needs.
- Assess the assumptions and risk factors underlying any forward-looking statements in the press release.